Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Leukemia 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myeloid, Acute 15Leukemia, Monocytic, Acute 9Leukemia, Myelomonocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 6Congenital Abnormalities 5Lymphoma 4Leukemia, Eosinophilic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Leukemia, Basophilic, Acute 3Myeloproliferative Disorders 2Anemia, Refractory, with Excess of Blasts 2Thrombocytopenia 1Sarcoma, Kaposi 1Sarcoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Down Syndrome 1Dendritic Cell Sarcoma, Interdigitating 1Anemia, Refractory 1AIDS-related Kaposi sarcoma 1

Interventions

Vincristine 4Prednisone 4Methotrexate 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Etoposide 4Doxorubicin 4Cytarabine 4Cyclophosphamide 4Leucovorin 3Methylprednisolone Hemisuccinate 2Methylprednisolone Acetate 2Methylprednisolone 2Hydrocortisone 2rasburicase 1pegfilgrastim 1pegaspargase 1merphos 1liposomal amphotericin B 1imetelstat 1hydrocortisone hemisuccinate 1Vancomycin 1Urate Oxidase 1Traumeel S 1Topotecan 1Thioguanine 1Tazobactam 1Rituximab 1Radiotherapy 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Dendritic Cell Sarcoma, Interdigitating × Daunorubicin × Clear all
NCT00002590 2014-07-24

Combination Chemotherapy in Treating Children With Lymphoma

Children's Oncology Group

Phase 2 Completed
221 enrolled
LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡